Brookfield Corporation Announces Redemption of Preference Shares (NYSE:BN)

BROOKFIELD, NEW YORK — September 4, 2026 — Leads & Copy — Brookfield Corporation announced today its intention to redeem all of its outstanding Cumulative Redeemable Class A Preference Shares, Series 51 and Series 52, for cash. The redemption is scheduled to occur on November 1, 2026.

The redemption price for each Series 51 Share is set at $22.44, which includes all accrued and unpaid dividends up to, but not including, the redemption date. For the Series 52 Shares, the redemption price is $22.00. Holders of Series 52 Shares who are on record as of October 15, 2026, will also receive the final quarterly dividend of $0.151250 per share, which is payable on October 30, 2026.

Brookfield Corporation is a global investment firm dedicated to building long-term wealth for institutions and individuals worldwide. The company operates through three primary business segments: Asset Management, Wealth Solutions, and its Operating Businesses, which encompass infrastructure, energy, private equity, and real estate.

With a history spanning over 30 years, Brookfield has consistently delivered annualized returns exceeding 15% to its shareholders, leveraging its extensive investment and operational experience. The firm emphasizes a conservatively managed balance sheet, broad operational expertise, and global sourcing capabilities to identify unique opportunities. A key element of Brookfield’s strategy is the Brookfield Ecosystem, designed to foster mutual benefits among its various organizational units.

Brookfield Corporation is publicly traded on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol BN. Its Class A Preference Shares, Series 51 are traded on the TSX under the ticker BN.PF.K, and its Class A Preference Shares, Series 52 are traded on the TSX under the ticker BN.PF.L.

Source: Brookfield Corporation

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.